Skip to main content

Table 1 Laboratory data on admission

From: Hepatic angiomyolipoma: differential diagnosis from other liver tumors in a special reference to vascular imaging - importance of early drainage vein

WBC 2,200/mm3 ChE 338 IU/L
RBC 405 × 104/mm3 Na 142 mEq/L
Hb 12.7 g/dL K 4.0 mEq/L
Ht 38.3% Cl 103 mEq/L
Plt 16.6 × 104/mm3 Ca 9.6 mg/dL
AST 17 IU/L CRP 0.02 mg/dL
ALT 14 IU/L Glucose 88 mg/dL
ALP 223 IU/L HbA1c 5.1%
LDH 144 IU/L CEA 2.6 ng/mL
γ-GTP 30 IU/L CA19-9 17.4 U/mL
T-Bil 0.8 mg/dL AFP 3.3 ng/mL
TP 7.0 g/dL AFP-L3 0.5%
Alb 4.5 g/dL PIVKA-II 15 mAU/mL
BUN 13.5 mg/dL HBS antigen (−)
Cre 0.52 mg/dL HCV antibody (−)
AMY 332 IU/L   
  1. WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; Ht, hematocrit; Plt, platelet; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; LDH, lactic dehydrogenase; γ-GTP, gamma glutamyl transpeptidase; T. Bil, total bilirubin; TP, total protein; Alb, albumin; BUN, blood urea nitrogen; Cr, creatinine; AMY, amylase; CHE, cholinesterase; Na, sodium; K, potassium; Cl, chloride; Ca, calcium; CRP, C-reactive protein; HbA1c, hemoglobin A1c; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; AFP, alpha-fetoprotein; AFP-L3, alpha-fetoprotein fraction L3; PIVKA-II, protein induced by vitamin K absence or antagonist-II; HBs antigen, hepatitis B surface antigen; HCV antibody, hepatitis C virus antibody.